Patient navigation shows benefits in prostate cancer care, but the evidence base is thin for African American men

African American men continue to bear a disproportionate burden of prostate cancer, and the care pathway is often shaped by delays, fragmented follow-up, and limited access to supportive services. A new scoping review mapped the navigation programs available across the cancer continuum and found a small, uneven literature that still leaves major gaps in how care is delivered to this high-risk group.

The review examined navigation interventions for African American/Black men in the United States from screening through survivorship. Only 8 studies met inclusion criteria out of 3,556 records identified, a remarkably small yield for a population facing persistent disparities. Most of the eligible studies were published before 2012, which means the field has not kept pace with the ongoing clinical need.

One finding stood out immediately: the intervention itself appears useful, but the research ecosystem around it is underdeveloped.

Care coordination, education, and emotional support formed the core of navigation

Across the included studies, the most common navigation tasks were care coordination, education and information provision, and comfort or emotional support. Those functions are not administrative extras; they directly shape whether a man completes screening, follows through on abnormal test results, reaches urology care, or stays engaged during treatment and survivorship.

In prostate cancer, where decision-making often hinges on timely testing, shared understanding of risk, and sustained follow-up, navigation can blunt the effects of structural barriers. Missed appointments, confusing referral chains, and gaps in health literacy can all slow diagnosis and treatment. A navigator can reduce those losses by helping patients understand next steps, arrange visits, and obtain support services that otherwise remain out of reach.

The review found that navigation improved screening uptake, prostate cancer management, and access to supportive services. Those outcomes fit the biology and the care process. Earlier detection matters because the disease is often clinically silent until it is more advanced, and care delays can widen disparities long before definitive treatment begins.

Early intervention appears useful, but the published studies rarely reflect modern practice

Only one study was published after 2012, leaving a long stretch in which contemporary navigation models, electronic care coordination tools, and more formal survivorship pathways were not represented. The timing matters because prostate cancer care has continued to evolve, while the social and structural barriers facing African American men have not diminished.

Two of the articles described the same navigation program, with one reporting the protocol and the other quasi-experimental results. That duplication further reduces the apparent size of the evidence base. Even so, the program-level findings were consistent enough to suggest that navigation can influence practical care outcomes when it is deployed in a structured way.

The mix of navigator types also mattered. Both clinical navigators, such as nurses, and non-clinical navigators, such as peers, were used. Clinical navigators may be better positioned to interpret medical details and coordinate across specialties, while peer navigators may be especially effective at building trust and helping patients persist through emotionally taxing decisions. In a disease where anxiety, mistrust, and system friction can all interfere with care, that human support is not incidental.

Training, cultural tailoring, and workforce design remain underreported

Only 3 articles provided information on navigator training. That is a significant omission because the effectiveness of navigation depends not just on the concept, but on the quality, preparation, and consistency of the person delivering it. Without a clearer description of training, it is difficult to know what skills are required, how navigators are supervised, or whether programs can be scaled reliably.

Even more limited was attention to cultural tailoring. Only 1 article addressed tailoring for African American/Black men. In a population with documented disparities in incidence and outcomes, the absence of culturally grounded design is a major gap. Trust, communication style, family engagement, beliefs about cancer, and prior experiences with the health system can all shape whether a patient uses navigation services effectively. Programs that ignore those realities risk delivering generic support where specific engagement is needed.

Disparity reduction depends on more than adding a navigator

The review reinforces a simple but important clinical principle: navigation can improve access, but access alone will not erase inequity if programs are sparse, outdated, or poorly adapted to the communities they intend to serve. African American men with prostate cancer face layered barriers, from screening to long-term follow-up, and those barriers require more than isolated assistance.

The data also suggest a broader implementation problem. Most of the literature is old, the sample of eligible studies is small, and the details needed for replication are often missing. Without clearer reporting on intervention content, navigator preparation, and cultural adaptation, it is difficult for health systems to know which components are essential and which are optional.

The practical bedside implication is straightforward. Urology clinics, oncology programs, and community outreach efforts cannot assume that a generic navigation model will be enough for African American men at risk for or living with prostate cancer. Programs need to be contemporary, measurable, and built around the barriers patients actually face.

A small literature base leaves major unanswered implementation questions

The review closes by showing both promise and incompleteness. Navigation programs appear beneficial for prostate cancer care, yet the literature remains too limited to define an optimal model for African American/Black men. The field still needs studies that reflect current practice, spell out navigator training, and test culturally tailored approaches across screening, treatment, and survivorship.

Until then, the evidence supports navigation as a useful strategy, but not as a finished solution. The next step is not simply more navigation; it is better navigation, studied in the population that stands to benefit most.


Reporting by Dr. Revathy Mohan V.R., MBBS for Medicine World Foundation, with additional data provided by NLM General Announcements.